Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 12, No 3 (2016) GENETIC PREDICTORS OF ATRIAL FIBRILLATION Abstract  PDF (Eng)  similar documents
A. V. Kuskaeva, S. Yu. Nikulina, A. A. Chernova, N. V. Aksyutina
"... the development of AF. The study of genes of renin-angiotensin-aldosterone system (RAAS) is especially important ..."
 
Vol 6, No 3 (2010) THE GENDER FEATURES OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS Abstract  similar documents
V. I. Podzolkov, A. E. Bragina, Ju. N. Rodionova, E. K. Panferova
"... Aim. To study the correlation of the renin-angiotensin-aldosterone system (RAAS) activity ..."
 
Vol 8, No 1 (2012) CURRENT TARGET OF ANTIHYPERTENSIVE THERAPY. DATA FROM CLINICAL TRIALS. PART 1 Abstract  similar documents
V. V. Popov, N. A. Bulanov, G. G. Ivanov
"... inhibit renin–angiotensin–aldosterone system (RAAS). Novel targets for antihypertensive therapy could ..."
 
Vol 8, No 2 (2012) CURRENT TARGET OF ANTIHYPERTENSIVE THERAPY. DATA FROM CLINICAL TRIALS. PART 2 Abstract  similar documents
V. V. Popov, N. A. Bulanov, G. G. Ivanov
"... inhibit renin–angiotensin–aldosterone system (RAAS). Novel targets for antihypertensive therapy could ..."
 
Vol 6, No 4 (2010) LISINOPRIL IMPLICATION IN THE CLINICAL PRACTICE Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova
"... of "cardiovascular continuum". Changes in neurohumoral factors especially activation of the renin-angiotensin ..."
 
Vol 4, No 2 (2008) CLINICAL AND GENETIC PECULIARITIES OF ATRIAL FIBRILLATION Abstract  similar documents
S. Y. Nikulina, V. A. Schulman, O. O. Kuznetsova, N. V. Aksjutina, P. A. Shesternja, A. A. Chernova, V. N. Maksimov, I. V. Kulikov, S. N. Ustinov, Y. L. Kazarinova, A. G. Romashchenko, M. I. Voevoda
"... Цель. Установить вероятность и закономерности наследования фибрилляции предсердий (ФП) в семьях ..."
 
Vol 8, No 3 (2012) EFFECT OF THE COMBINED ANTIHYPERTENSIVE THERAPY WITH TARGET BLOOD PRESSURE ACHIEVEMENT ON INTRARENAL BLOOD FLOW IN PATIENTS WITH TYPE 2 DIABETES Abstract  similar documents
O. A. Koshel'skaya, O. A. Zhuravleva
"... antihypertensive therapy with or without renin-angiotensin-aldosterone system (RAAS) inhibitors. Material ..."
 
Vol 16, No 1 (2020) An Attempt to Accord the Quality of Therapy of Stable Coronary Heart Disease Patients with Current Clinical Guidelines (ALIGN study): Design and the First Results Abstract  similar documents
S. Yu. Martsevich, E. D. Zharkova, N. P. Kutishenko, Yu. V. Lukina, S. N. Tolpygina, V. P. Voronina, A. V. Zagrebelnyy
"... %, and renin-angiotensin-aldosterone system (RAAS) blockers – in 80% of cases. Conclusions. Initial quality ..."
 
Vol 5, No 2 (2009) CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL Abstract  similar documents
D. A. Napalkov, E. N. Golovenko
 
Vol 8, No 4 (2012) UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION Abstract  similar documents
E. A. Protasova, N. V. Furman, O. V. Reshet'ko
"... Inhibitors of the renin-angiotensin-aldosterone system, statins, and possibly , ω-3 ..."
 
Vol 5, No 4 (2009) ANTIARRHYTMIC EFFICACY OF SOTALOL IN PATIENTS WITH TACHY-BRADY SYNDROME HAVING ATRIAL PACEMAKER WITH DIFFERENT ATRIAL ELECTRODE POSITION Abstract  similar documents
T. N. Novikova
"... ) and in right atrial auricle (RAA). Material and methods. 20 patients with tachy-brady syndrome were examined ..."
 
Vol 15, No 3 (2019) Genetic, Epigenetic and Transcription Factors in Atrial Fibrillation Abstract  similar documents
O. V. Sapelnikov, A. A. Kulikov, O. O. Favorova, N. A. Matveeva, D. I. Cherkashin, O. A. Nikolaeva, R. S. Akchurin
"... заболеваниями, является фибрилляция предсердий (ФП). Врожденные формы ФП достаточно редки. Многие исследования ..."
 
Vol 4, No 4 (2008) PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY Abstract  similar documents
S. A. Boytsov, I. P. Kolos
"... Angiotensin II receptor antagonists (ARA) established their position recently duet to new ..."
 
Vol 14, No 3 (2018) CARDIOPROTECTIVE PROPERTIES OF LISINOPRIL: NEW POSSIBILITIES Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova, R. G. Gataulin
"... angiotensin converting enzyme inhibitors or angiotensin II receptor blockers. The follow-up duration was from ..."
 
Vol 20, No 4 (2024) Nephroprotective and anticoagulant therapy in patients with atrial fibrillation and chronic kidney disease: real-world data Abstract  similar documents
A. I. Listratov, I. I. Ivanov, N. K. Ziskina, V. V. Efimenko, A. V. Zhavoronkova, E. S. Milyakova, A. A. Kudrjavtseva, D. A. Napalkov, A. A. Sokolova
"... characteristics were retrospectively assessed, as were the use of renin-angiotensin system inhibitors (RASi ..."
 
Vol 8, No 5 (2012) EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN ACHIEVEMENT OF TARGET BLOOD PRESSURE IN DIABETIC PATIENTS Abstract  similar documents
O. A. Koshel'skaya, O. A. Zhuravleva, R. S. Karpov
"... -angiotensin-aldosterone system (RAAS) blockers, indapamide and calcium channel blocker (CCB) in hypertensive ..."
 
Vol 17, No 5 (2021) Genetic Polymorphism of beta1-adrenergic Receptors and the Effect on the Clinical Efficacy of beta-adrenoblockers Abstract  similar documents
V. N. Larina, M. V. Leonova
"... БАБ во многом зависит от генетического полиморфизма бета1-адренорецепторов (ADRB1). Целью обзора ..."
 
Vol 16, No 4 (2020) Telocytes and Atrial Fibrillation: From Basic Research to Clinical Practice Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova, A. S. Frolova
"... молекулярные причины фибрилляции предсердий (ФП). В последнее время активно обсуждается роль интерстициальных ..."
 
Vol 13, No 2 (2017) PATIENTS WITH COMBINATION OF CHRONIC HEART FAILURE, HYPERTENSION AND HISTORY OF MYOCARDIAL INFARCTION: CLINICAL AND ANAMNESTIC CHARACTERISTICS, ADMINISTRATION OF ACE INHIBITORS, ANGIOTENSIN RECEPTOR BLOCKERS, -BLOCKERS AND ADHERENCE TO THE DRUG THERAPY (DATA OF OUTPATIENT REGISTRY RECVASA) Abstract  similar documents
M. M. Loukianov, A. N. Kozminsky, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, A. V. Zagrebelnyy, R. P. Myasnikov, K. G. Pereverzeva, E. A. Pravkina, E. Yu. Andreenko, E. N. Belova, A. D. Deev, V. G. Klyashtorny, E. V. Kudryashov, S. A. Boytsov
"... Aim. To assess the clinical and anamnestic characteristics, the prescription rate of angiotensin ..."
 
Vol 15, No 1 (2019) Personalized Medicine in the Treatment of Atrial Fibrillation: Myth or Reality? Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova
"... индивидуального лечения становятся реальностью. Наиболее широкое распространение получили генетические ..."
 
Vol 18, No 1 (2022) Polymorbidity and Polypragmasia in High and Very High Cardiovascular Risk Patients Abstract  similar documents
N. V. Izmozherova, A. A. Popov, A. A. Kuryndina, E. I. Gavrilova, M. A. Shambatov, V. M. Bakhtin
"... of prognosis modifying medication prescribing, patients with CHF in 107 (63.0%) cases received angiotensin ..."
 
Vol 13, No 1 (2017) EVALUATION OF TREATMENT OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION BEFORE REFERENCE EVENT AND BEFORE DISCHARGE FROM THE HOSPITAL: REGISTER DATA (KHABAROVSK CITY). PART 2 Abstract  similar documents
L. N. Malay, S. Yu. Martsevich, L. V. Solokhina, Y. M. Bukhonkina, K. E. Poshatayev, N. B. Garayeva, A. Ya. Letskin
"... .8%). Results. Before reference AMI a frequency of administration of statins was 13.7%, angiotensin-renin ..."
 
Vol 20, No 5 (2024) The effect of the M235T polymorphism of the angiotensinogen gene on the office blood pressure during therapy with angiotensin II receptor blockers Abstract  similar documents
E. V. Rebrova, E. V. Shikh
"... Aim. To study the pharmacodynamic parameters of the effectiveness of therapy with angiotensin II ..."
 
Vol 6, No 3 (2010) ASSOCIATION OF CLINICAL AND GENETIC FACTORS WITH LEFT VENTRICLE HYPERTROPHY IN ARTERIAL HYPERTENSION Abstract  PDF (Eng)  similar documents
T. Yu. Kuznetsova, D. V. Gavrilov, L. M. Samohodskaya, D. V. Rebrikov, S. A. Morozova, P. I. Makarevich, A. V. Kolotvin, A. B. Balatsky, A. Yu. Postnov, S. A. Boitsov
"... NO synthase (eNOS) Glu298Asp gene, the C242T of the NADPH oxidase p22phox subunit and the angiotensin 2 ..."
 
Vol 4, No 3 (2008) ANGIOTENSIN II AND MYOCARDIAL INFARCTION Abstract  similar documents
O. P. Shevchenko, А. О. Shevchenko
"... The role of angiotensin II in pathogenesis of cardiovascular diseases is discussed. Angiotensin II ..."
 
Vol 5, No 4 (2009) TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS Abstract  similar documents
L. N. Malay, A. N. Miroshnichenko, B. V. Sharykin, V. V. Konurovsky
"... Angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) slow ..."
 
Vol 13, No 3 (2017) ANGIOTENSIN RECEPTOR BLOCKERS WITH PLEIOTROPIC PROPERTIES: A NEW STANDARD IN CARDIOVASCULAR RISK MANAGEMENT AND TREATMENT OF HYPERTENSION Abstract  similar documents
V. I. Podzolkov, M. V. Pisarev
"... An increase in the activity of the renin-angiotensin-aldosterone system is one of the most ..."
 
Vol 9, No 4 (2013) ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: IS THERE A REASON TO CONSIDER AN EQUIVALENCE OF TWO DRUG CLASSES FROM THE EVIDENCE BASED MEDICINE STANDPOINT Abstract  similar documents
S. Yu. Martsevich
"... ) and angiotensin receptor blockers (ARB) on cardiovascular diseases outcomes are evaluated. Data of the recent meta ..."
 
Vol 16, No 2 (2020) Treatment of Patients with COVID-19 and Concomitant Cardiovascular Diseases: Do not Forget About the Principles of Evidence-based Medicine Abstract  similar documents
S. Yu. Martsevich
"... The recent discussion about the dangers of using angiotensin-converting-enzyme (ACE) inhibitors ..."
 
Vol 16, No 6 (2020) Patients with Atrial Fibrillation in Clinical Practice: Comorbidity, Drug Treatment and Outcomes (Data from RECVASA Registries) Abstract  similar documents
M. M. Loukianov, E. Yu. Andreenko, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, E. Yu. Okshina, V. V. Yakusevich, V. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, V. G. Klyashtorny, E. V. Kudryashov, Ju. E. Tatsii, S. A. Boytsov, O. M. Drapkina
"... ) was associated with the prescription of anticoagulants, angiotensin-converting enzyme (ACE) inhibitors ..."
 
Vol 19, No 1 (2023) Relief of persistent atypical atrial flutter: experience with the use of niferidil Abstract  similar documents
E. A. Zakharyan, D. V. Shatov, A. O. Povoroznyj, T. B. Bujar
"... . Фибрилляция и трепетание предсердий являются одними из самых распространенных причин снижения качества жизни и ..."
 
Vol 10, No 5 (2014) OUTPATIENT REGISTRY OF CARDIOVASCULAR DISEASES (RECVASA): PROSPECTIVE FOLLOW-UP DATA, ESTIMATION OF RISKS AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  PDF (Eng)  similar documents
M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov
"... .01, respectively). Patients treated with ACE inhibitors or angiotensin receptor blockers (ARB) had lower all-cause ..."
 
Vol 10, No 6 (2014) IRBESARTAN IN THE CLINICAL PRACTICE Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova
"... (myocardial infarction, stroke, chronic heart and renal failure). Angiotensin receptor blockers are the first ..."
 
Vol 3, No 4 (2007) RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION Abstract  similar documents
I. V. Szirov, E. V. Malichenko
"... Angiotensin converting enzyme inhibitors are the first line medicine for the treatment of the most ..."
 
Vol 8, No 2 (2012) TELMISARTAN IN THE TREATMENT OF ARTERIAL HYPERTENSION. CASE STUDY Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova
"... Data on angiotensin II receptor blockers, one of the main drug classes used in cardiology ..."
 
Vol 7, No 2 (2011) PREDICTIVE ROLE OF CONNEXIN 40 IN THE PATHOGENESIS OF HEREDITARY SICK SINUS SYNDROME Abstract  similar documents
S. Yu. Nikulina, A. A. Chernova, V. A. Shulman, T. S. Kukushkina, M. I. Voevoda, V. N. Maksimov
"... стимуляции предсердий. Молекулярно-генетическое обследование больных СССУ и их родственников проводили в ..."
 
Vol 13, No 5 (2017) POLYMORPHISMS OF ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE AS PREDICTORS OF WOLFF-PARKINSON-WHITE SYNDROME Abstract  similar documents
G. V. Matyushin, S. Yu. Nikulina, A. A. Chernova, I. I. Lebedeva, A. A. Semenchukov
"... Открытие новых генетических предикторов сердечно-сосудистых заболеваний может использоваться при ..."
 
Vol 14, No 5 (2018) Associations of Cardiovascular Risk Factors and Genetic Markers with Development of Arterial Hypertension in the Population of Mountain Shoriya Abstract  similar documents
T. A. Mulerova, S. A. Maksimov, M. Yu. Ogarkov, O. V. Gruzdeva, A. V. Ponasenko, V. N. Maksimov, M. I. Voyevoda, E. S. Filimonov, G. V. Artamonova
"... the proteins of the main components of neurophysiological systems (renin-angiotensin-aldosterone, sympathetic ..."
 
Vol 9, No 2 (2013) A META-ANALYSIS REPORTING EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTSWITHOUT HEART FAILURE Abstract  similar documents
G. Savarese, P. Costanzo, J.G.F. Cleland, E. Vassallo, D. Ruggiero, G. Rosano, P. Perrone-Filardi
"... . Rosano, P. Perrone-Filardi «A Meta-Analysis Reporting Effects of Angiotensin-Converting Enzyme Inhibitors ..."
 
Vol 9, No 2 (2013) ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: ISN'T IT TIME TO DRAW A LINE UNDER DISCUSSION ABOUT SUPERIORITY Abstract  similar documents
S. Yu. Martsevich
"... Comments to the paper G. Savarese et al. A Meta-Analysis Reporting Effects of Angiotensin ..."
 
Vol 17, No 5 (2021) Long-term Results of Drug and Interventional Treatment in Patients with Morphologically Verified Idiopathic Arrhythmias Abstract  similar documents
O. V. Blagova, A. V. Nedostup, E. A. Kogan
"... включены 20 больных (средний возраст 43,1±11,3 лет, 10 женщин) с фибрилляцией предсердий (ФП ..."
 
Vol 6, No 5 (2010) THE POLYMORPHISM OF Α2B-ADRENERGIC RECEPTOR GENE — A NEW GENETIC MARKER OF THE HEREDITARY SICK SINUS SYNDROME Abstract  similar documents
S. Iu. Nikulina, V. A. Shulman, A. A. Chernova, D. A. Nikulin, M. I. Voevoda, V. N. Maksimov
"... исследование, эхокардиоскопия. Молекулярно-генетическое исследование проводилось в лаборатории медицинской ..."
 
Vol 11, No 1 (2015) ATRIAL FIBRILLATION ASSOCIATED WITH MYOCARDIAL INFARCTION OF DIFFERENT LOCALIZATIONS Abstract  similar documents
R. Bhattarai, S. A. Sayganov, E. V. Trofimova
"... Цель. Уточнение механизмов развития фибрилляции предсердий (ФП) и оценка функции левого предсердия ..."
 
Vol 10, No 3 (2014) THE CAPABILITIES OF A REGISTER AS A QUALITY CONTROL OF THE PHARMACOTHERAPY IN OUTPATIENTS AT HIGH RISK OF CARDIOVASCULAR COMPLICATIONS (THE "LIS-1" REGISTER) Abstract  similar documents
M. L. Ginzburg, S. Y. Martsevich, N. P. Kutishenko, Y. V. Lukina, A. D. Deev
"... receiving b-blockers, 35.3% - renin-angiotensin-aldosterone system (RAAS) inhibitors, 15.7% - antiplatelet ..."
 
Vol 13, No 3 (2017) HYPERTHYROIDISM AND ATRIAL FIBRILLATION Abstract  similar documents
I. M. Marusenko, E. G. Petrova
"... Представлен обзор литературы по проблеме особенностей развития фибрилляции предсердий у больных ..."
 
Vol 12, No 5 (2016) The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin Abstract  similar documents
I. Yu. Koroleva, I. V. Kolesnichenko, V. P. Nosov, M. V. Zlobin, D. I. Abelevich
"... предсердий (ФП) в сравнении с варфарином Материал и методы. В открытое нерандомизированное исследование ..."
 
Vol 7, No 1 (2011) ATRIAL FLUTTER: CONTEMPORARY POSSIBILITIES OF DIAGNOSIS AND TREATMENT Abstract  similar documents
Yu. A. Bunin
"... Диагностика и лечение трепетания предсердий (ТП) является актуальной проблемой. Представлены ..."
 
Vol 6, No 1 (2010) ANTITHROMBOTIC THERAPY AT AN ATRIAL FIBRILLATION: OLD PROBLEMS AND NEW SOLUTIONS Abstract  similar documents
M. Yu. Gilyarov, V. A. Sulimov
"... Обсуждается проблема выбора антитромботической терапии при фибрилляции предсердий. Помимо давно ..."
 
Vol 10, No 3 (2014) PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN ATRIAL FIBRILLATION - RAT POISON OR NEW ORAL ANTICOAGULANTS: DO WE HAVE A CHOICE, AND SHOULD WE BE AFRAID TO MAKE IT? FIRST CLINICAL EXPERIENCE WITH RIVAROXABAN IN NIZHNY NOVGOROD Abstract  similar documents
L. Y. Koroleva, I. V. Kolesnichenko, V. P. Nosov, I. I. Gritsenko, E. S. Timoschenko
"... Одним из основных направлений ведения больных с фибрилляцией предсердий является адекватная ..."
 
Vol 11, No 6 (2015) PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN ATRIAL FIBRILLATION - RAT POISON OR NEW ORAL ANTICOAGULANTS: DO WE HAVE A CHOICE, AND SHOULD WE BE AFRAID TO MAKE IT? FIRST CLINICAL EXPERIENCE WITH RIVAROXABAN IN NIZHNY NOVGOROD Abstract  similar documents
L. Y. Koroleva, I. V. Kolesnichenko, V. P. Nosov, I. I. Gritsenko, E. S. Timoschenko
"... Одним из основных направлений ведения больных с фибрилляцией предсердий является адекватная ..."
 
Vol 17, No 6 (2021) Atrial Fibrillation in Cancer Patients: Who is at Risk? Abstract  similar documents
Yu. A. Vasyuk, E. Yu. Shupenina, D. A. Vyzhigin, E. O. Novosel, K. V. Gallinger
"... категорий пациентов, особенно пожилых, является фибрилляция предсердий (ФП).  Учитывая тот факт, что в ..."
 
Vol 5, No 3 (2009) ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN MANAGEMENT OF PATIENTS WITH CHRONIC HEART FAILURE Abstract  similar documents
S. N. Tereshchenko, N. A. Dzhaiani
 
Vol 9, No 6 (2013) POSSIBILITY OF ANGIOTENSIN RECEPTOR BLOCKERS IN OPTIMIZING OF ANTIHYPERTENSIVE PHARMACOTHERAPY IN PATIENTS AFTER STROK Abstract  similar documents
Z M. Sizova
 
Vol 1, No 1 (2005) EXPERT CONSENSUS DOCUMENT ON ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CARDIOVASCULAR DISEASE Abstract  similar documents
Jose Lopez-Sendon, Karl Swedberg, John McMurray, Juan Tamargo, Aldo P. Maggioni, Henry Dargie, Michal Tendera, Finn Waagstein, Jan Kjekshus, Philippe Lechat, Christian Torp-Pedersen
"... Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. ..."
 
Vol 3, No 1 (2007) THE CAPABILITIES OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CLINICAL PRACTICE: FOCUS ON VASOPROTECTION Abstract  similar documents
D. B. Nebieridze, A. S. Safaryan
"... Data of large-scale research that shows comprehensive abilities of an angiotensin converting ..."
 
Vol 4, No 5 (2008) INHIBITION OF KIDNEY DISORDERS IN CARDIOVASCULAR DISEASES: THE ROLE OF ANGIOTENSIN II RECEPTOR BLOCKERS Abstract  similar documents
V. V. Fomin
"... and cardiovascular complications are discussed with focus on usage of angiotensin II receptor blockers. ..."
 
Vol 18, No 6 (2022) The Effect of Angiotensin Receptor and Neprilysin Inhibitors on Quality of Life in Patients with Heart Failure with Reduced Ejection Fraction and Functional Mitral Regurgitation Abstract  similar documents
A. S. Ryazanov, E. V. Shikh, O. V. Kechina, M. V. Makarovskaya, A. A. Kudryavtsev
 
Vol 7, No 1 (2011) SUPPRESSION OF RENIN-ANGIOTENSIN SYSTEM TO PREVENT COMPLICATIONS OF CARDIOVASCULAR DISEASES: CURRENT "ROLES" DISTRIBUTION FROM CLINICAL PHARMACOLOGIST’S POINT OF VIEW Abstract  similar documents
S. R. Gilyarevskiy, V. A. Orlov, M. V. Golshmid, G. Yu. Zakharova, I. I. Sinitsina
"... A role of angiotensin-converting enzyme (ACE) inhibitors in cardiovascular diseases treatment ..."
 
Vol 6, No 1 (2010) ANGIOTENSIN II RECEPTOR ANTAGONISTS AND ACE INHIBITORS: OPTIMIZATION OF CHOICE FOR TREATMENT OF CARDIOVASCULAR DISEASES Abstract  similar documents
E. M. Khurs, A. V. Poddubnaya
"... Aim. To evaluate the cardioprotective effects of ACE inhibitor, ramipril and angiotensin II ..."
 
Vol 6, No 6 (2010) NEW POSSIBILITIES OF STATIN THERAPY IN ARTERIAL HYPERTENSION Abstract  similar documents
E. M. Khurs, A. V. Poddubnaya, M. G. Evsina, E. M. Futerman, O. G. Smolenskaya
"... .23. Patients were randomized into 4 treatment groups: Group A1 (angiotensin converting enzyme (ACE) inhibitors ..."
 
Vol 6, No 5 (2010) THE USE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS AFTER MYOCARDIAL INFARCTION. WHAT DO EVIDENCE-BASED MEDICINE DATA SPEAK FOR? Abstract  similar documents
S. Yu. Martsevich
"... The main trails proven angiotensin converting enzyme (ACE) inhibitor effects on the life prognosis ..."
 
Vol 10, No 3 (2014) RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND REPLICATIVE CELLULAR SENESCENCE: THEIR INTERACTION DURING THE VASCULAR AGEING Abstract  similar documents
V. S. Pykhtina, I. D. Strazhesko, M. V. Agaltsov, O. N. Tkacheva
"... is paid to the activation of the renin-angiotensin-aldosterone system as a source of chronic inflammation ..."
 
Vol 11, No 6 (2015) Cardiometabolic properties of telmisartan: new perspectives for use Abstract  similar documents
O. M. Drapkina, E. I. Fomicheva
 
Vol 3, No 3 (2007) ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: WHEN TO START THERAPY AND WHICH DRUG TO USE? Abstract  similar documents
S. Y. Martsevich, S. N. Tolpygina
"... Data of studies devoted to application of angiotensin converting enzyme (ACE) inhibitors in acute ..."
 
Vol 3, No 5 (2007) EFFECT OF SPIRAPRIL ON THE LENGTH OF INTERICTAL INTERVAL IN PAROXYSMAL ATRIAL FIBRILLATION Abstract  similar documents
L. N. Chikhireva, V. I. Malahov, E. S. Bykova, S. F. Sokolov
"... Aim. To evaluate effects of angiotensin converting enzyme inhibitor spirapril on efficacy ..."
 
Vol 15, No 2 (2019) Current Predictors of Atrial Fibrillation Progression Abstract  PDF (Eng)  similar documents
V. I. Podzolkov, A. I. Tarzimanova
"... Цель. Выявить предикторы прогрессирования фибрилляции предсердий (ФП) у пациентов с артериальной ..."
 
Vol 17, No 6 (2021) Drug-Induced Atrial Fibrillation / Atrial Flutter Abstract  similar documents
O. D Ostroumova, M. S. Chernyaeva, A. I. Kochetkov, A. E. Vorobieva, D. I. Bakhteeva, S. P. Korchagina, O. V. Bondarets, N. D. Boyko, D. A. Sychev
"... Лекарственно-индуцированная фибрилляция/трепетание предсердий (ЛИФП/ТП) представляет собой ..."
 
Vol 17, No 3 (2021) Left Atrial Function in Different Modes of Heart-Rate Lowering Therapy with Beta-Blockers in Patients with Recurrent Atrial Fibrillation and Hypertension Abstract  similar documents
E. V. Kokhan, G. K. Kiyakbaev, E. M. Ozova, V. A. Romanova, Zh. D. Kobalava
"... функцию левого предсердия (ЛП) у пациентов с рецидивирующей малосимптомной фибрилляцией предсердий (ФП) на ..."
 
Vol 13, No 4 (2017) ATRIAL FIBRILLATION AND ARTERIAL HYPERTENSION: GENDER DIFFERENCES OF VENTRICULOATRIAL REMODELING WITH PRESERVED EJECTION FRACTION Abstract  similar documents
Zh. D. Kobalava, E. V. Kokhan, G. K. Kiyakbaev, A. A. Shavarov
"... особенностей эпидемиологии, патогенеза и прогностического значения фибрилляции предсердий (ФП). Структурная и ..."
 
Vol 10, No 2 (2014) CHANGE OF LOCAL MYOCARDIAL CONTRACTILITY DUE TO SELECTION OF DIFFERENT ARRHYTHMIA TREATMENT STRATEGIES IN PATIENTS WITH ISCHEMIC HEART DISEASE AND PAROXYSMAL ATRIAL FIBRILLATION Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova
"... ) с пароксизмальной формой фибрилляции предсердий (ФП) при лечении амиодароном в суточной дозе 200 мг ..."
 
Vol 10, No 3 (2014) THE FIRST EXPERIENCE OF LEFT ATRIAL APPENDAGE OCCLUDING DEVICES IMPLANTATION FOR PREVENTION OF STROKE IN THE STATE RESEARCH CENTRE FOR PREVENTIVE MEDICINE Abstract  similar documents
K. V. Davtyan, O. N. Tkacheva, A. A. Kalemberg, S. N. Koretsky
"... предсердий, в частности, имплантация окклюзирующих устройств в ушко левого предсердия. Помимо обзора данных ..."
 
Vol 15, No 5 (2019) Left Atrial Phasic Function in Patients with Hypertension and Recurrent Atrial Fibrillation: Gender Differences of the Relationship with Diastolic Dysfunction and Central Aortic Pressure Abstract  similar documents
E. V. Kokhan, E. M. Ozova, V. A. Romanova, G. K. Kiyakbaev, Zh. D. Kobalava
"... Цель. Изучить гендерные особенности функции левого предсердия (ЛП) в разные фазы и его ..."
 
Vol 12, No 2 (2016) ATRIAL FIBRILLATION: CURRENT PROBLEMS AND PROSPECTS OF MEDICAL CARE, TREATMENT AND PREVENTION Abstract  similar documents
Ju. P. Skirdenko, A. V. Shustov, V. V. Zherebilov, N. A. Nikolaev
"... Рассмотрены современные подходы к антиаритмической противорецидивной терапии фибрилляции предсердий ..."
 
Vol 12, No 5 (2016) Statins in Secondary Prevention of Atrial Fibrillation Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova, R. G. Gataulin
"... гипертонией с пароксизмальной формой фибрилляции предсердий (ФП) при многолетнем проспективном наблюдении ..."
 
Vol 12, No 5 (2016) Pathogenic Mechanisms of Atrial Fibrillation in Obesity Abstract  similar documents
O. M. Drapkina, M. V. Nikolaeva
"... Фибрилляция предсердий (ФП) является одной из наиболее распространенных аритмий. Ее появление ..."
 
Vol 7, No 2 (2011) PHARMACOEPIDEMIOLOGICAL ANALYSIS OF THE TREATMENT OF PAROXYSMAL AND PERSISTENT ATRIAL FIBRILLATION IN EVERY DAY CLINICAL PRACTICE Abstract  similar documents
I. V. Graifer, O. V. Reshet'ko, N. V. Furman
"... Цель. Анализ сложившейся клинической практики терапии фибрилляции предсердий (ФП) в отделении ..."
 
Vol 13, No 1 (2017) ANTIPLATELET THERAPY OF ATRIAL FIBRILLATION: FOCUS ON THE ELDERLY Abstract  similar documents
E. А. Ushkalova, S. K. Zyryanov, E. V. Dumchenko
"... В современных руководствах по лечению  фибрилляции предсердий (ФП) в качестве препаратов выбора ..."
 
Vol 7, No 5 (2011) ANALYSIS OF DIRECT COSTS ASSOCIATED WITH THE USE OF WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
Yu. B. Belousov, I. S. Yavelov, D. Yu. Belousov, E. V. Afanasieva
"... международного нормализованного отношения (МНО) при терапии больных с фибрилляцией предсердий (ФП) в расчёте на 1 ..."
 
Vol 2, No 1 (2006) PROPAFENONE FOR SINUS RHYTHM RECOVERY AND SUPPORT IN PATIENTS WITH PERSISTENT FORM OF AURICULAR FIBLILLATION. “PROMETHEUS” – OPENED MULTICENTER STUDY IN RUSSIAN FEDERATION Abstract  similar documents
I. G. Fomina, A. I. Tarzimanova, A. V. Vetluzsky, , , , , , , , , , , , , , , , ,
"... удержании синусового ритма у больных с персистирующей формой фибрилляции предсердий (ФП). Материал и методы ..."
 
Vol 9, No 4 (2013) ATRIAL FIBROSIS IS A MORPHOLOGICAL BASIS OF ATRIAL FIBRILLATION Abstract  similar documents
O. M. Drapkina, A. V. Emelyanov
"... больных фибрилляцией предсердий. Обсуждают новые терапевтические подходы к лечению фибрилляции предсердий ..."
 
Vol 10, No 4 (2014) MODERN APPROACHES TO ANTICOAGULANT THERAPY DURING CATHETER ABLATION TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
E. A. Belikov, K. V. Davtyan, O. N. Tkacheva
"... предсердий, подвергшихся катетерной изоляции устьев легочных вен. Представлен обзор данных литературы по этой ..."
 
Vol 11, No 6 (2015) Cardiac involvement in lymphomas. Review of literature and case report of the clinical course of B-large-cell lymphoma Abstract  similar documents
I. Yu. Gadaev, V. I. Ershov, O. V. Bochkarnikova, I. Ya. Sokolova, D. A. Budanova, E. S. Kotova, A. S. Lishuta
 
Vol 8, No 3 (2012) RIVAROXABAN IN THE PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
M. Yu. Gilyarov
"... Освещены возможности антитромботической терапии при фибрилляции предсердий. Наряду с традиционными ..."
 
Vol 8, No 4 (2012) THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY Abstract  similar documents
M. Yu. Gilyarov
"... Освещен ряд современных антитромботических средств, применяемых при фибрилляции предсердий. Наряду ..."
 
Vol 16, No 5 (2020) Changes in Antithrombotic Therapy of Atrial Fibrillation in the Hospital in 2011-2012 and 2016-2017 (Pharmacoepidemiological Analysis) Abstract  similar documents
O. V. Reshetko, A. V. Sokolov, N. V. Furman, V. V. Agapov
"... Цель. Изучить изменения, произошедшие в фармакотерапии фибрилляции предсердий (ФП) в Саратовской ..."
 
Vol 17, No 1 (2021) Asymptomatic Supraventricular Arrhythmias in Patients Undergoing Dialysis Abstract  similar documents
O. V. Likhachev-Mishchenko, A. A. Kornienko, N. A. Kornienko, L. A. Khaisheva, A. A. Dyuzhikov, S. V. Shlyk
"... [ОР] 1,04 в год; 95% доверительный интервал [ДИ] 1,00-1,08) и увеличение размера правого предсердия ..."
 
Vol 15, No 5 (2019) Comparative Analysis of Factors Affecting the Prognosis of Patients with Atrial Fibrillation According to the Results of the REKUR-AF Study Abstract  similar documents
I. L. Polshakova, S. V. Povetkin
"... выживаемость пациентов с фибрилляцией предсердий (ФП) в исследовании РЕКУР-ФП. Материал и методы. В базу ..."
 
Vol 19, No 5 (2023) Patients with atrial fibrillation in outpatient practice: clinical characteristics and outcomes over a 10-year observation period (data from the REQUAZA AF registrу — Yaroslavl) Abstract  similar documents
V. V. Yakusevich, V. Vl. Yakusevich, S. Yu. Martsevich, M. M. Lukyanov, O. M. Drapkina
"... предсердий (ФП) в одной из поликлиник г. Ярославля. Материал и методы. 212 пациентов с ФП в возрасте от 23 ..."
 
Vol 15, No 3 (2019) Hypertension and Headache: the Effect of Antihypertensive Drugs Abstract  similar documents
V. A. Parfenov, T. M. Ostroumova, O. D. Ostroumova
"... of hyperactivation of the renin-angiotensin-aldosterone and adrenergic system and endothelial dysfunction ..."
 
Vol 13, No 5 (2017) LEFT ATRIAL FUNCTION: MODERN ASSESSMENT METHODS AND CLINICAL SIGNIFICANCE Abstract  similar documents
E. N. Pavlyukova, D. A. Kuzhel, G. V. Matyushin
"... Оценка функции левого предсердия (ЛП) является важным аспектом всестороннего исследования ..."
 
Vol 14, No 3 (2018) NEW-ONSET ATRIAL FIBRILLATION IN SETTINGS OF ACUTE CORONARY SYNDROME. CURRENT ISSUES Abstract  similar documents
G. S. Galjautdinov1, I. V. Gorelkin, K. R. Ibragimova, R. R. Sadriev
"... Настоящий обзор посвящен теме впервые возникшей фибрилляции предсердий (ФП) в условиях острого ..."
 
Vol 20, No 5 (2024) Association between renin-angiotensin system gene polymorphism and cardio-ankle vascular index in patients with COVID-19 Abstract  similar documents
V. I. Podzolkov, A. E. Bragina, E. S. Ogibenina, I. I. Shvedov, A. R. Komelkova
"... Aim. To assess the relationship between arterial stiffness and renin-angiotensin system (RAS) gene ..."
 
Vol 8, No 6 (2012) SARTANS AND ANGIOTENSIN CONVERTING ENZYME INHIBITORS: A DUEL BETWEEN TWO LEADERS OF PHARMACOTHERAPY OF CARDIOVASCULAR DISEASES Abstract  similar documents
K. A. Gyamdzhyan, M. L. Maksimov
"... -angiotensin-aldosterone system are discussed. Efficacy and safety of two major cardiovascular drug classes ..."
 
Vol 5, No 6 (2009) ORGANOPROTECTIVE EFFECTS OF THE FIXED COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR LISINOPRIL AND DIURETIC HYDROCHLOROTHIAZIDE Abstract  similar documents
E. A. Ryabikhin, M. E. Mozheiko
 
Vol 10, No 2 (2014) ADVANTAGES OF COMBINATION THERAPY OF HYPERTENSION WITH CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN-CONVERTING ENZYME INHIBITOR IN PATIENTS WITH IMPAIRED RENAL FUNCTION Abstract  similar documents
N. A. Dzhaiani
"... lercanidipine and angiotensin-converting enzyme inhibitor enalapril. ..."
 
Vol 9, No 2 (2013) FIXED COMBINATION OF THE CALCIUM CHANNEL BLOCKER LERCANIDIPINE AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL: POSSIBILITY OF USAGE Abstract  similar documents
O. D. Ostroumova, I. I. Kopchenov
"... for different clinical situations are presented. Advantages and indications for combination of an angiotensin ..."
 
Vol 3, No 2 (2007) CORRECTION OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH CHRONIC COR PULMONALE BY ANGIOTENSIN II RECEPTORS ANTAGONISTS Abstract  similar documents
V. S. Zadionchenko, N. B. Holodkova, O. I. Nesterenko, I. V. Pogonchenkova, A. M. Shchikota, Y. V. Ignatova, I. Y. Malyshev, E. B. Manukhina, S. V. Kruglov, D. A. Pokidyshev, O. A. Zemnina
"... and peripheral hemodynamics and to evaluate how these characteristics are influenced by angiotensin II receptors ..."
 
Vol 3, No 2 (2007) OXIDATIVE STRESS AND POSSIBILITY TO CORRECT IT WITH ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN PATIENTS WITH MYOCARDIAL INFARCTION ASSOCIATED WITH DIABETES MELLITUS TYPE 2 Abstract  similar documents
K. S. Lexina, N. Y. Timofeeva, V. S. Zadionchenko, G. G. Shehian, K. A. Aldushina
"... dysfunction and atherogenesis. There are data that angiotensin converting enzyme inhibitor, zofenopril, has ..."
 
Vol 3, No 3 (2007) REDUCTION OF CUMULATIVE CARDIOVASCULAR RISK IN PATIENTS WITH ARTERIAL HYPERTENSION: THE ROLE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS ACCORDING TO THE NEW EUROPEAN RECOMMENDATIONS Abstract  similar documents
M. N. Mamedov, N. A. Chepurina, Z. N. Tokareva, A. A. Evdokimova
"... of antihypertensive drugs in mono- and combined therapy. Angiotensin converting enzyme (ACE) inhibitors keep important ..."
 
Vol 3, No 5 (2007) CUMULATIVE CARDIO-VASCULAR RISK IN HYPERTENSIVE PATIENTS: EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS Abstract  similar documents
L. I. Katelnitskaya, L. A. Haisheva, S. E. Glova
 
1 - 100 of 551 Items 1 2 3 4 5 6 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)